Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Point of Care Ultrasound for Bedside Diagnosis of Hypertrophic Cardiomyopathy in the Post-anesthesia Care Unit.

SN comprehensive clinical medicine·2026
Same author

Association of Dexmedetomidine Use With Complete Heart Block After Transcatheter Aortic Valve Replacement: A Retrospective Single-Center Cohort Study.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

In Response.

Anesthesia and analgesia·2026
Same author

Perioperative Best Practices and Delirium in Patients With Cognitive Impairment.

JAMA network open·2026
Same author

High sensitivity troponin-I and myocardial injury after noncardiac surgery for cancer in a large prospective cohort.

BMC anesthesiology·2025
Same author

Anesthesia Type during Cancer Surgery: Results of the GA-CARES Randomized, Multicenter Trial.

Anesthesiology·2025

Related Experiment Video

Updated: Mar 28, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
06:05

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection

Published on: October 12, 2017

16.3K

Methylene Blue: Magic Bullet for Vasoplegia?

Leila Hosseinian1, Menachem Weiner, Matthew A Levin

  • 1From the *Department of Anesthesiology, and †Department of Cardiothoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.

Anesthesia and Analgesia
|December 19, 2015
PubMed
Summary

Methylene blue (MB) effectively raises blood pressure in vasodilatory shock. However, its impact on oxygen delivery and mortality remains unproven, necessitating further large trials for critical care use.

More Related Videos

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

21.9K
An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse
06:39

An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse

Published on: September 12, 2018

29.2K

Related Experiment Videos

Last Updated: Mar 28, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
06:05

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection

Published on: October 12, 2017

16.3K
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

21.9K
An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse
06:39

An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse

Published on: September 12, 2018

29.2K

Area of Science:

  • Pharmacology
  • Critical Care Medicine
  • Anesthesiology

Background:

  • Distributive shock states are characterized by profound vasodilation.
  • Methylene blue (MB) is recognized for its potential to counteract this vasodilation.

Purpose of the Study:

  • To review the pharmacologic properties of methylene blue.
  • To evaluate the efficacy and safety of MB in treating shock across critical care, liver transplantation, and cardiac anesthesia literature.

Main Methods:

  • Literature review of critical care, liver transplantation, and cardiac anesthesia studies.
  • Analysis of pharmacologic properties of methylene blue.

Main Results:

  • Consistent improvements in blood pressure have been observed with MB in smaller studies.
  • Evidence for improved oxygen delivery or reduced mortality with MB is currently lacking.

Conclusions:

  • Methylene blue shows promise in improving hemodynamics in shock states.
  • Large randomized controlled trials are essential to establish the definitive role of MB in hemodynamic resuscitation.